Oncology

Latest News

The report suggests a TBS cutoff value of 3 will serve as a meaningful prognostic tool in HCC, but differences in patient populations and imaging techniques may affect the value of that cutoff, the authors noted. | Image credit: Jo Panuwat D - stock.adobe.com

HCC Tumor Burden Score Predicts Long-Term Outcomes Following MWA

By Jared Kaltwasser

May 7th 2025

Patients with a high tumor burden score had poorer outcomes following microwave ablation, the investigators found.

Doctor showing lung x ray | Image credit: didesign – stock.adobe.com

Tarlatamab Safety Varies Between Clinical and Real-World SCLC Trials

By Hayden E. Klein

May 6th 2025

CureCancer | Image Credit: © MMPhoto21-sotck.adobe.com

COA 2025: Insight, Innovation, and Independent Strength

By Maggie L. Shaw

May 5th 2025

Community Oncology Reacts to Trump's Drug Pricing Executive Order

By Maggie L. Shaw

May 2nd 2025

Melanoma & Skin Cancer Awareness Month | Image credit: Waseem Ali Khan - stock.adobe.com

5 Things You Should Know About Skin Cancer

By Pearl Steinzor

May 2nd 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

February 18th 2015

FDA Expands Indication for Revlimid in Multiple Myeloma

Laura Joszt, MA

The combination of Revlimid with dexamethasone, previously approved for treatment in patients with multiple myeloma who received at least 1 prior treatment, has received FDA approval for use in newly diagnosed multiple myeloma patients.

February 18th 2015

Study Identifies Potential Biomarker for Cabazitaxel Response in CRPC

The study published in Clinical Cancer Research elucidated an in vitro mechanism that could explain why cabazitaxel is more effective in some prostate cancer patients. The study also identified a biomarker that could provide precision medicine for a subset of patients.

February 17th 2015

Oncologist to Launch Social Media Campaign Against Cost of Cancer Drugs

Following his collaboration with other research scientists to protest the cost of cancer drugs, Hagop Kantarjian, MD, from the MD Anderson Cancer Center has now turned to patients.

February 17th 2015

Doctors Need to Be Tech Savvy, Report Suggests

The survey, conducted by salesforce.com, showed that 71% patients want their doctor to use a mobile application to schedule appointments, share health data, and manage preventive care; 60% patients reported an interest in using telehealth in place of in-person visits.

February 17th 2015

Cancer Patients Associated Shared-Decision Making With Quality Care

Laura Joszt, MA

Cancer patients with less involvement in their treatment decisions are less likely to report excellent quality of care even if they prefer physician-controlled decisions, according to a study in JAMA Oncology.

February 17th 2015

Study Urges Lung Cancer Trials to Include Survivors

The study, published in the Journal of the National Cancer Institute, found that having a prior cancer diagnosis did not affect outcomes among the patients with advanced lung cancer, which means these patients should be allowed to take part in clinical trials of new lung cancer treatments.

February 16th 2015

Improving the Value of Immune-Based Therapies

Richard W. Joseph, MD

February 16th 2015

Issues Impacting Stakeholder Adoption of Immuno-Oncology

Bruce Feinberg, DO

February 16th 2015

New Standards of Care in the Management of Prostate Cancer

Surabhi Dangi-Garimella, PhD

February 16th 2015

Payers Evaluate the Clinical Utility of Diagnostic Tests

Surabhi Dangi-Garimella, PhD

February 16th 2015

Innovation and the Role of Alternative Markers of Efficacy

Sejal Saraiya, PharmD

February 16th 2015

The Use and Implementation of Standardized Treatment Pathways

Sejal Saraiya, PharmD

February 16th 2015

Arguments Taking Shape For and Against FDA Regulation of Diagnostic Tests

Mary K. Caffrey

February 16th 2015

HHS Announces New Oncology Care Management Initiative

Laura Joszt, MA

February 16th 2015

FDA Updates

Surabhi Dangi-Garimella, PhD

February 16th 2015

Study Results Support Early Treatment With Abiraterone in Prostate Cancer

Surabhi Dangi-Garimella, PhD

February 16th 2015

ASCO Announces Partner for CancerLinQ Platform

Mary K. Caffrey

February 16th 2015

ASCO Demands Medicaid Reform

Surabhi Dangi-Garimella, PhD

February 16th 2015

Hormonal Imbalance in Adult Survivors of Pediatric Cranial Tumors Reported

Investigators at St. Jude Children's Research Hospital found that decades after undergoing cranial irradiation for childhood cancer, adult survivors remain at risk for pituitary hormone deficiencies that may diminish their health and quality of life.

February 16th 2015

FDA Approves Palbociclib for Metastatic Breast Cancer

Silas Inman

February 16th 2015

Reality Meets ASCO's Policy Statement on Medicaid Reform

Ted Okon, MBA

February 16th 2015

Lung Cancer Breath Test Might Soon Be Reality

Researchers at the University of Leicester and Leicester's Hospitals are evaluating a revolutionary device which detects lung cancer in early stages.

February 16th 2015

Patient Cost-Sharing in Oncology and the Patient Access Network Foundation

Dan Klein

February 15th 2015

Commission on Cancer and the Oncology Medical Home

Daniel P. McKellar, MD, FACS

February 15th 2015

Immuno-Oncology Poised to Revolutionize Patient Care

Lee S. Schwartzberg, MD, FACP

February 15th 2015

The Promise of Immuno-Oncology

Surabhi Dangi-Garimella, PhD

February 15th 2015

Money Well Spent: the Need for Federal Funding in Cancer Research

John R. Seffrin, PhD

February 14th 2015

Managed Care Minute: February 14, 2015

A one-minute look at managed care news during the week of February 9, 2015, including an announcement of a new Affordable Care Initiative and a potential change to recommended dietary guidelines.

February 13th 2015

Cancer Patients Rarely Request Inappropriate Tests, Treatments

Laura Joszt, MA

A new study debunks the common assumption that high medical costs are a result of patients demanding more tests and treatments. Researchers analyzed more than 5000 patient-clinician visits and found that cancer patients rarely push for medical interventions.

February 12th 2015

Order of Cancer Gene Mutations Could Influence Treatment Choice

The NEJM study, although specific for blood disorders, could be extrapolated to other tumor types as well, to develop personalized treatment regimens, the authors suggest.

...

137 138 139 140 141 142 143 144 145

...

184 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions